210 related articles for article (PubMed ID: 24709425)
1. Lung-derived factors mediate breast cancer cell migration through CD44 receptor-ligand interactions in a novel ex vivo system for analysis of organ-specific soluble proteins.
Chu JE; Xia Y; Chin-Yee B; Goodale D; Croker AK; Allan AL
Neoplasia; 2014 Feb; 16(2):180-91. PubMed ID: 24709425
[TBL] [Abstract][Full Text] [Related]
2. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability.
Croker AK; Goodale D; Chu J; Postenka C; Hedley BD; Hess DA; Allan AL
J Cell Mol Med; 2009 Aug; 13(8B):2236-2252. PubMed ID: 18681906
[TBL] [Abstract][Full Text] [Related]
3. The effect of soluble E-selectin on tumor progression and metastasis.
Kang SA; Blache CA; Bajana S; Hasan N; Kamal M; Morita Y; Gupta V; Tsolmon B; Suh KS; Gorenstein DG; Razaq W; Rui H; Tanaka T
BMC Cancer; 2016 May; 16():331. PubMed ID: 27220365
[TBL] [Abstract][Full Text] [Related]
4. Tartrate-resistant acid phosphatase (TRAP/ACP5) promotes metastasis-related properties via TGFβ2/TβR and CD44 in MDA-MB-231 breast cancer cells.
Reithmeier A; Panizza E; Krumpel M; Orre LM; Branca RMM; Lehtiö J; Ek-Rylander B; Andersson G
BMC Cancer; 2017 Sep; 17(1):650. PubMed ID: 28915803
[TBL] [Abstract][Full Text] [Related]
5. Soluble bone-derived osteopontin promotes migration and stem-like behavior of breast cancer cells.
Pio GM; Xia Y; Piaseczny MM; Chu JE; Allan AL
PLoS One; 2017; 12(5):e0177640. PubMed ID: 28498874
[TBL] [Abstract][Full Text] [Related]
6. CD44 targets Na(+)/H(+) exchanger 1 to mediate MDA-MB-231 cells' metastasis via the regulation of ERK1/2.
Chang G; Wang J; Zhang H; Zhang Y; Wang C; Xu H; Zhang H; Lin Y; Ma L; Li Q; Pang T
Br J Cancer; 2014 Feb; 110(4):916-27. PubMed ID: 24434427
[TBL] [Abstract][Full Text] [Related]
7. Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior.
Piaseczny MM; Pio GM; Chu JE; Xia Y; Nguyen K; Goodale D; Allan A
J Vis Exp; 2016 Jun; (112):. PubMed ID: 27341354
[TBL] [Abstract][Full Text] [Related]
8. CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions.
Shirure VS; Liu T; Delgadillo LF; Cuckler CM; Tees DF; Benencia F; Goetz DJ; Burdick MM
Am J Physiol Cell Physiol; 2015 Jan; 308(1):C68-78. PubMed ID: 25339657
[TBL] [Abstract][Full Text] [Related]
9. Enhanced cell surface CD44 variant (v6, v9) expression by osteopontin in breast cancer epithelial cells facilitates tumor cell migration: novel post-transcriptional, post-translational regulation.
Khan SA; Cook AC; Kappil M; Günthert U; Chambers AF; Tuck AB; Denhardt DT
Clin Exp Metastasis; 2005; 22(8):663-73. PubMed ID: 16691370
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin increases hepatocellular carcinoma cell growth in a CD44 dependant manner.
Phillips RJ; Helbig KJ; Van der Hoek KH; Seth D; Beard MR
World J Gastroenterol; 2012 Jul; 18(26):3389-99. PubMed ID: 22807608
[TBL] [Abstract][Full Text] [Related]
11. CD44 attenuates metastatic invasion during breast cancer progression.
Lopez JI; Camenisch TD; Stevens MV; Sands BJ; McDonald J; Schroeder JA
Cancer Res; 2005 Aug; 65(15):6755-63. PubMed ID: 16061657
[TBL] [Abstract][Full Text] [Related]
12. CD44v4 is a major E-selectin ligand that mediates breast cancer cell transendothelial migration.
Zen K; Liu DQ; Guo YL; Wang C; Shan J; Fang M; Zhang CY; Liu Y
PLoS One; 2008 Mar; 3(3):e1826. PubMed ID: 18350162
[TBL] [Abstract][Full Text] [Related]
13. Effects of VEGFR1
Meng D; Meng M; Luo A; Jing X; Wang G; Huang S; Luo M; Shao S; Zhao X; Liu R
J Cancer Res Clin Oncol; 2019 Feb; 145(2):411-427. PubMed ID: 30483898
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin prevents skeletal metastasis of breast cancer by an antagonistic interplay between p53 and CD44.
Mandal CC; Ghosh-Choudhury N; Yoneda T; Choudhury GG; Ghosh-Choudhury N
J Biol Chem; 2011 Apr; 286(13):11314-27. PubMed ID: 21199873
[TBL] [Abstract][Full Text] [Related]
15. A CD44v
Hu J; Li G; Zhang P; Zhuang X; Hu G
Cell Death Dis; 2017 Mar; 8(3):e2679. PubMed ID: 28300837
[TBL] [Abstract][Full Text] [Related]
16. Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells.
Uchino M; Kojima H; Wada K; Imada M; Onoda F; Satofuka H; Utsugi T; Murakami Y
BMC Cancer; 2010 Aug; 10():414. PubMed ID: 20696077
[TBL] [Abstract][Full Text] [Related]
17. A novel mechanism of regulating breast cancer cell migration via palmitoylation-dependent alterations in the lipid raft affiliation of CD44.
Babina IS; McSherry EA; Donatello S; Hill AD; Hopkins AM
Breast Cancer Res; 2014 Feb; 16(1):R19. PubMed ID: 24512624
[TBL] [Abstract][Full Text] [Related]
18. Deletion of the thrombin cleavage domain of osteopontin mediates breast cancer cell adhesion, proteolytic activity, tumorgenicity, and metastasis.
Beausoleil MS; Schulze EB; Goodale D; Postenka CO; Allan AL
BMC Cancer; 2011 Jan; 11():25. PubMed ID: 21247495
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer stem cells: mechanobiology reveals highly invasive cancer cell subpopulations.
Alvarez-Elizondo MB; Weihs D
Cell Mol Life Sci; 2022 Feb; 79(3):134. PubMed ID: 35171381
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells.
Bourguignon LY; Singleton PA; Zhu H; Zhou B
J Biol Chem; 2002 Oct; 277(42):39703-12. PubMed ID: 12145287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
